These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 8562414)
1. Blood clonal B-cell excess in patients with monoclonal gammopathy of undetermined significance (MGUS): association with malignant transformation. Isaksson E; Björkholm M; Holm G; Johansson B; Nilsson B; Mellstedt H; Osterborg A Br J Haematol; 1996 Jan; 92(1):71-6. PubMed ID: 8562414 [TBL] [Abstract][Full Text] [Related]
2. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy. Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962 [TBL] [Abstract][Full Text] [Related]
3. Malignant transformation in IgM monoclonal gammopathy of undetermined significance. Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132 [TBL] [Abstract][Full Text] [Related]
4. Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands. van de Poel MH; Coebergh JW; Hillen HF Br J Haematol; 1995 Sep; 91(1):121-5. PubMed ID: 7577618 [TBL] [Abstract][Full Text] [Related]
5. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ]. Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009 [TBL] [Abstract][Full Text] [Related]
6. [Follow-up of monoclonal gammopathy of undetermined significance in a population of 51 patients older than 70 years ]. Decaux O; Cazalets-Lacoste C; Cador-Rousseau B; Laurat E; Sebillot M; Bracq J; Jego P; Leblay R; Grosbois B Rev Med Interne; 2002 Sep; 23(9):751-8. PubMed ID: 12378828 [TBL] [Abstract][Full Text] [Related]
7. The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients. Cao XX; Meng Q; Mao YY; Su W; Zhen JF; Shen KN; Zhang CL; Huang XF; Duan MH; Zhang W; Zhu TN; Cai HC; Chen M; Zhou DB; Li J Leuk Res; 2016 Jul; 46():85-8. PubMed ID: 27232065 [TBL] [Abstract][Full Text] [Related]
8. Presence of monoclonal free light chains in the serum predicts risk of progression in monoclonal gammopathy of undetermined significance. Rajkumar SV; Kyle RA; Therneau TM; Clark RJ; Bradwell AR; Melton LJ; Larson DR; Plevak MF; Katzmann JA Br J Haematol; 2004 Nov; 127(3):308-10. PubMed ID: 15491291 [TBL] [Abstract][Full Text] [Related]
9. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma. Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113 [TBL] [Abstract][Full Text] [Related]
10. Circulating monotypic B-cells in multiple myeloma: association with lambda paraproteins. Bagg A; Becker P; Bezwoda W; van Rensburg L; Mendelow B Br J Haematol; 1989 Jun; 72(2):167-72. PubMed ID: 2503024 [TBL] [Abstract][Full Text] [Related]
11. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Rajkumar SV; Kyle RA; Therneau TM; Melton LJ; Bradwell AR; Clark RJ; Larson DR; Plevak MF; Dispenzieri A; Katzmann JA Blood; 2005 Aug; 106(3):812-7. PubMed ID: 15855274 [TBL] [Abstract][Full Text] [Related]
12. [Malignant transformation of monoclonal gammopathy of undetermined significance]. Decaux O; Avet-Loiseau H; Grosbois B Presse Med; 2007 Dec; 36(12 Pt 3):1985-96. PubMed ID: 17509811 [TBL] [Abstract][Full Text] [Related]
13. Blood clonal B cell excess (CBE) at diagnosis in patients with non-Hodgkin lymphoma (NHL). Relation to clinical stage, histopathology and response to treatment. Lindemalm C; Mellstedt H; Nilsson B; Biberfeld P; Björkholm M; Christensson B; Holm G; Johansson B Eur J Cancer Clin Oncol; 1987 Jun; 23(6):749-53. PubMed ID: 3115783 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal gammopathy of unknown significance and malignant paraproteinemia in Hong Kong. Lolin YI; Chow J; Wickham NW Am J Clin Pathol; 1996 Oct; 106(4):449-56. PubMed ID: 8853031 [TBL] [Abstract][Full Text] [Related]
15. Blood clonal B cell excess at diagnosis in multiple myeloma: relation to prognosis. Osterborg A; Nilsson B; Björkholm M; Holm G; Johansson B; Lindemalm C; Petterson D; Ahre A; Mellstedt H Eur J Haematol; 1987 Feb; 38(2):173-8. PubMed ID: 3109935 [TBL] [Abstract][Full Text] [Related]
17. Risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance. Pasqualetti P; Casale R Biomed Pharmacother; 1997; 51(2):74-8. PubMed ID: 9161471 [TBL] [Abstract][Full Text] [Related]
18. Restricted expression of immunoglobulin light chain mRNA and of the adhesion molecule CD11b on circulating monoclonal B lineage cells in peripheral blood of myeloma patients. Jensen GS; Belch AR; Kherani F; Mant MJ; Ruether BA; Pilarski LM Scand J Immunol; 1992 Dec; 36(6):843-53. PubMed ID: 1281335 [TBL] [Abstract][Full Text] [Related]
19. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma. Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439 [TBL] [Abstract][Full Text] [Related]
20. Monoclonal gammopathy in general practice. Diagnostic value of typing and quantitation of immunoglobulins. Schmidt EB; Møller-Petersen J Scand J Prim Health Care; 1985 May; 3(2):91-4. PubMed ID: 3933073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]